Follow
Wai-Kay Seto 司徒偉基
Wai-Kay Seto 司徒偉基
Department of Medicine, The University of Hong Kong, Hong Kong
Verified email at hku.hk
Title
Cited by
Cited by
Year
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
HI Yang, MF Yuen, HLY Chan, KH Han, PJ Chen, DY Kim, SH Ahn, ...
The lancet oncology 12 (6), 568-574, 2011
6762011
Epidemiology of hepatocellular carcinoma in the Asia-Pacific region
RX Zhu, WK Seto, CL Lai, MF Yuen
Gut and liver 10 (3), 332, 2016
5642016
Chronic hepatitis B virus infection
WK Seto, YR Lo, JM Pawlotsky, MF Yuen
The Lancet 392 (10161), 2313-2324, 2018
5172018
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind …
M Buti, E Gane, WK Seto, HLY Chan, WL Chuang, T Stepanova, AJ Hui, ...
The lancet Gastroenterology & hepatology 1 (3), 196-206, 2016
4852016
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non …
HLY Chan, S Fung, WK Seto, WL Chuang, CY Chen, HJ Kim, AJ Hui, ...
The lancet Gastroenterology & hepatology 1 (3), 185-195, 2016
4572016
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
K Agarwal, M Brunetto, WK Seto, YS Lim, S Fung, P Marcellin, SH Ahn, ...
Journal of hepatology 68 (4), 672-681, 2018
3802018
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study
WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ...
Journal of Clinical Oncology 32 (33), 3736-3743, 2014
3512014
Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs
ML Grayson, SM Crowe, JS McCarthy, J Mills, JW Mouton, SR Norrby, ...
CRC press, 2010
345*2010
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease
MF Yuen, WK Seto, DHF Chow, K Tsui, DKH Wong, VWS Ngai, ...
Antiviral therapy 12 (8), 1295-1304, 2007
3322007
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
J Fung, CL Lai, WK Seto, MF Yuen
Journal of antimicrobial chemotherapy 66 (12), 2715-2725, 2011
2722011
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
WK Seto, AJ Hui, VWS Wong, GLH Wong, KSH Liu, CL Lai, MF Yuen, ...
Gut 64 (4), 667-672, 2015
2352015
hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection
LY Mak, DKH Wong, KS Cheung, WK Seto, CL Lai, MF Yuen
Alimentary pharmacology & therapeutics 47 (1), 43-54, 2018
2272018
Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety
MF Yuen, WK Seto, J Fung, DKH Wong, JCH Yuen, CL Lai
Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011
2032011
Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA
DKH Wong, WK Seto, KS Cheung, CK Chong, FY Huang, J Fung, CL Lai, ...
Liver International 37 (7), 995-1001, 2017
1962017
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma
DKH Wong, FY Huang, CL Lai, RTP Poon, WK Seto, J Fung, IFN Hung, ...
Hepatology 54 (3), 829-836, 2011
1932011
Reduction of covalently closed circular DNA with long-term nucleos (t) ide analogue treatment in chronic hepatitis B
CL Lai, D Wong, P Ip, M Kopaniszen, WK Seto, J Fung, FY Huang, B Lee, ...
Journal of hepatology 66 (2), 275-281, 2017
1892017
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1702022
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
WK Seto, DKH Wong, J Fung, FY Huang, KSH Liu, CL Lai, MF Yuen
Clinical Microbiology and Infection 20 (11), 1173-1180, 2014
1662014
Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos (t) ide analogues of different potency
DKH Wong, WK Seto, J Fung, P Ip, FY Huang, CL Lai, MF Yuen
Clinical gastroenterology and hepatology 11 (8), 1004-1010. e1, 2013
1572013
Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B
J Fung, SC Chan, C Cheung, MF Yuen, KSH Chok, W Sharr, ACY Chan, ...
Official journal of the American College of Gastroenterology| ACG 108 (6 …, 2013
1412013
The system can't perform the operation now. Try again later.
Articles 1–20